Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation.
Miki
T
T
Thomas E. Starzl Transplantation Institute, Pittsburgh, PA 15261, USA.
Goller
A
A
Rao
A
A
Wang
X
X
Yin
W Y
WY
Tandin
A
A
Fung
J J
JJ
Starzl
T E
TE
Valdivia
L A
LA
D000818:Animals; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004357:Drug Synergism; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D006168:Guinea Pigs; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051381:Rats; D011917:Rats, Inbred Lew; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000401:mortality
D007166:Immunosuppressive Agents; D007555:Isoxazoles; D003520:Cyclophosphamide; D000077339:Leflunomide; D009173:Mycophenolic Acid; D016559:Tacrolimus